The Biden admin is out the door. But we’re only scratching the surface of his horrors.
And now a bombshell report has unveiled the Biden admin’s disturbing acts with kids.
Joe Biden’s $1 Billion Investment in S*xual And Gender Minority Research Sparks Debate on Child S*x Changes
A lesser-known division of the National Institutes of Health (NIH), the S*xual And Gender Minority Research Office (SGMRO), has channeled over $1 billion into research on S*xual And Gender minorities (SGM), including controversial studies on experimental s*x-change treatments for children, according to a review of NIH grants by reporters.
Launched in 2015, the SGMRO is tasked with advancing “rigorous research on the health of SGM populations,” which includes individuals identifying as lesbian, gay, bis*xual, as*xual, transgender, non-binary, Two-Spirit, qu**r, and inters*x. Although the office does not directly allocate grants, it plays a significant role in coordinating and facilitating research across NIH, helping secure hundreds of millions in funding annually for studies on the health of S*xual And Gender minorities.
In the past decade, the SGMRO has been pivotal in directing funding for a wide array of studies, some of which focus on sensitive issues, such as the psychological effects of puberty blockers on minors. Under the Biden administration, the NIH’s funding for SGM research saw a marked increase, with at least 100 additional studies being funded each year from 2021 to 2024 compared to the previous administration.
However, the focus of some of these studies, particularly those involving minors, has raised concerns among critics. One such critic, Stella O’Malley, director of Genspect, a nonpartisan organization advocating for “non-medicalized solutions to gender distress,” expressed her worries in an email to reporters: “If the SGMRO is supporting research involving experimental medical interventions in minors, this requires thorough investigation.”
O’Malley, who is particularly concerned about the use of puberty blockers and cross-s*x hormones in children, noted the absence of long-term evidence to support these treatments and pointed out the risks involved. “Government funding for studies on puberty blockers and cross-s*x hormones in healthy children is deeply concerning, given the lack of evidence for long-term benefits and the growing documentation of significant physical and psychological risks,” she stated, adding that “most gender-distressed youth” resolve their issues without medical intervention. “These experiments are both unnecessary and harmful.”
Despite these concerns, several NIH-funded studies continue to investigate the effects of medical treatments like puberty blockers and cross-s*x hormones on minors. Research on such topics has gained increasing public attention, particularly as public opinion polls show that a growing number of Americans oppose medical s*x-change treatments for minors.
Michael Costa, editor-in-chief of Gays Against Groomers, an organization of LGBTQ+ individuals who oppose medical s*x changes for minors, argued that what is being labeled as “gender-affirming care” is, in reality, “pharmaceutical conversion therapy.” He described these treatments as “nothing more than a euphemistic label for genital mutilation and s*x lobotomy.”
The funding of such studies has become a politically charged issue. In the lead-up to his 2024 presidential campaign, former President Donald Trump made combating gender ideology a cornerstone of his platform. On his first day in office, Trump signed an executive order ensuring that the federal government would only recognize the two immutable s*xes: male and female. In a recent move, Trump directed federal diversity, equity, and inclusion staff to be placed on paid leave and eventually removed from government payrolls, signaling his commitment to cutting what he views as unnecessary government spending.
TRUMP: “As of today, it will henceforth be the official policy of the United States government that there are only two genders: MALE and FEMALE.”
That's the way it should be—common sense and reality.
👏 👏 👏 pic.twitter.com/UwHp1bB0WV
— Gays Against Groomers (@againstgrmrs) January 20, 2025
The future of the SGMRO and its funding is uncertain under the current political climate. Both the NIH and the SGMRO have not responded to multiple inquiries about the office’s status under the Trump administration. However, past reports detail a wide range of studies funded through various NIH offices, many of which are detailed in the office’s 2023 report.
Among the studies receiving significant funding, some stand out as particularly controversial. Here are five of the most unusual SGMRO studies, which collectively received more than $2 million in NIH funding:
Experimental Hormone Testing on Minors – $707,054
Stanford University received over $707,000 from the National Institute of Mental Health to study the effects of cross-s*x hormones on the brains of minors. The research is focused on “early pubertal adolescents,” a group for which there has been very little previous research. This study, which will run until May 2025, is seen as pivotal in filling gaps in understanding the impact of cross-s*x hormone treatment on developing brains.
Puberty Blockers Study – $1,111,300
Children’s Hospital of Los Angeles received over $1.1 million from the Eunice Kennedy Shriver National Institute of Child Health and Human Development for a study that administers puberty blockers to children and young adults, ranging from 8 to 20 years old. The project, led by Dr. Johanna Olson-Kennedy, one of the nation’s most well-known practitioners of youth gender medicine, has faced significant scrutiny. Olson-Kennedy has expressed caution about releasing the data, citing the potential for political backlash. Despite this, the study has received a total of $9.7 million in government funding as of October 2024.
HIV Research in Malaysia – $100,000
The National Institute on Drug Abuse provided $100,000 for a study at Yale University investigating the HIV epidemic in Malaysia. The study focuses on at-risk groups, including men who have s*x with men, female s*x workers, and people who inject drugs. The research aims to improve HIV prevention and treatment for S*xual And Gender minorities in the region.
Investigating the Stress of Rural Gay Couples – $481,970
A study funded by the National Institute on Alcohol Abuse and Alcoholism and the National Institute of General Medical Sciences was conducted by the University of Nebraska. The research, costing nearly half a million dollars, examines alcohol use among economically disadvantaged S*xual And Gender minority couples in rural areas. The study aimed to show that alcohol use is linked to unhealthy relationships, with results expected to contribute to a sense of community for LGBTQ+ couples.
Testosterone’s Impact on V*ginal Bacteria – $283,494
The University of Alabama at Birmingham received funding from the National Institute of Allergy and Infectious Diseases to study the effects of testosterone on v*ginal bacteria. The researchers sought to determine whether testosterone use could have negative consequences, potentially increasing the diversity of bacteria linked to conditions like bacterial v*ginosis. This study is part of an ongoing effort to optimize testosterone therapy for transgender men.
The creation of the SGMRO followed a 2011 NIH report under the Obama administration that found a significant lack of health research focused on LGBTQ populations. Critics, like Joseph Figliolia, a gender policy analyst at the Manhattan Institute, suggest that while the SGMRO could contribute to evidence-based medicine, many researchers may approach their studies with “predetermined conclusions.” Figliolia added that the SGMRO’s influence on NIH research priorities might be steering funding toward gender-affirming treatments despite a lack of conclusive evidence on their effectiveness.
“The problem is that the SGMRO shapes the types of studies that get funded,” Figliolia explained. “I find it deeply troubling that the NIH would continue to promote the practice of transitioning minors despite the lack of evidence and refusal to put their evidence forward.”
Clementine, the detransitioner🦎suing Dr. Johannah Olson-Kennedy for medical negligence, shares what she wishes the doctor told her before pushing puberty blockers, hormones, and a double mastectomy.
"I really wish she sort of interrogated my ideas about womanhood."… pic.twitter.com/hEMuGzLke3
— Elizabeth Troutman Mitchell (@TheElizMitchell) December 11, 2024
The Conservative Column will bring you any updates to this story as it is uncovered.
